Table 1.
Commercial | Medicare | Medicaid | |
---|---|---|---|
Enrolled patients | 11,053,733 | 1,229,651 | 2,791,550 |
≥18 years of age | 10,586,378 | 1,229,651 | 2,415,776 |
Received oral atypical antipsychotic | 919,872 | 136,038 | 496,092 |
Enrolled continuously 6 months prior and 12 months after first oral atypical and ≥ 18 in year indexed | 366,234 | 62,946 | 210,367 |
Exclude if antipsychotic through mail order | 304,118 | 42,097 | 207,149 |
Exclude if index fill for clozapine | 303,157 | 41,945 | 204,130 |
Has claims during atypical enrollment window | 303,157 | 41,945 | 204,130 |
≥1 inpatient or ≥ 2 outpatient claims with a diagnosis code for SCZ, BPD, or MDD during 6 months prior to index date or 12 months after | 241,648 | 26,502 | 168,441 |
SCZ schizophrenia, BPD bipolar disorder, MDD: major depressive disorder